Amicus Therapeutics downgraded by Leerink Partners with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for FOLD
Across the 5 sessions after earlier FOLD headlines, the stock closed higher 4 times and lower 1 times, with a median move of 1.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | FOLD | SPY |
|---|---|---|---|
| Dec 22, 2025 | Amicus Therapeutics downgraded by TD Cowen with a new price target | +0.2% | +0.6% |
| Dec 17, 2025 | Citigroup initiated coverage on Amicus Therapeutics with a new price target | +1.0% | -1.1% |
| Nov 4, 2025 | Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates | +1.5% | -1.2% |
| Oct 31, 2025 | Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025 | +1.5% | +0.3% |
| Oct 23, 2025 | Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025 | -0.6% | +0.6% |
Quantisnow market dataNASDAQ
FOLD
Amicus Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2007
Get push alerts for FOLD
Full FOLD profile on Quantisnow Follow FOLD and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time